Trials / Completed
CompletedNCT01870882
Attention Training for Opioid-maintained Cocaine Users
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- Yale University · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the feasibility and preliminary efficacy of attention training using a portable electronic device for opioid-dependent cocaine-users stabilized on methadone.
Detailed description
The investigators propose to test the feasibility and preliminary efficacy of 5-times per week daily attentional retraining (AR) delivered via a portable electronic device (PED) in comparison with a control condition over the course of a 2-3 week training period. Participants in this study will be cocaine and opioid-dependent individuals stabilized on methadone. Both cocaine and opioids will be targeted in the AR procedure the investigators will test in this study. The retraining or control condition, along with a series of assessments, will be delivered on the PED as part of a daily (Monday through Friday) appointment at which time participants will also obtain their daily methadone dose. Assessments will cover substance use, craving and other issues. In addition to completing the retraining or control procedure, participants will also be engaged in standard versions of attentional bias tasks (i.e., without retraining) periodically in order to gauge an effect of study condition on attentional bias over time. Thus, the investigators will be able to track changes in attentional bias over time in a more detailed fashion than has been previously possible. Following the 3 week training period, there will be another 3 weeks of treatment in which patients will continue to receive methadone and complete limited assessments without any AR or control procedures with the PED.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Attentional retraining | |
| BEHAVIORAL | Control condition |
Timeline
- Start date
- 2013-06-01
- Primary completion
- 2014-12-01
- Completion
- 2015-06-01
- First posted
- 2013-06-06
- Last updated
- 2020-04-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01870882. Inclusion in this directory is not an endorsement.